Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 34

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 3
Chunk 34
---
 provision may limit
our shareholders’ ability to bring a claim in a judicial forum that they find favorable.

In determining whether to
enforce a jury trial waiver provision, New York courts and federal courts will consider whether the visibility of the jury trial waiver
provision within the agreement is sufficiently prominent such that a party has knowingly waived any right to trial by jury. We believe
that this is the case with respect to the deposit agreement and the ADSs. In addition, New York courts will not enforce a jury trial waiver
provision in order to bar a viable setoff or counterclaim sounding in fraud or one which is based upon a creditor’s negligence in
failing to liquidate collateral upon a guarantor’s demand, or in the case of an intentional tort claim (as opposed to a contract
dispute), none of which we believe are applicable in the case of the deposit agreement or the ADSs. No condition, stipulation or provision
of the deposit agreement or ADSs serves as a waiver by any holder or beneficial owner of ADSs or by us or the Depositary of compliance
with any provision of the federal securities laws. If you or any other holder or beneficial owner of ADSs brings a claim against us or
the Depositary in connection with matters arising under the deposit agreement or the ADSs, you or such other holder or beneficial owner
may not be entitled to a jury trial with respect to such claims, which may have the effect of limiting and discouraging lawsuits against
us and/or the Depositary.

If a lawsuit is brought
against us and/or the Depositary under the deposit agreement, it may be heard only by a judge or justice of the applicable trial
court, which would be conducted according to different civil procedures and may determine different results than a trial by jury
would have had, including results that could be less favorable to the plaintiff(s) in any such action, depending on, among other
things, the nature of the claims, the judge or justice hearing such claims, and the venue of the hearing.

As the jury trial waiver relates
to claims arising out of or relating to the ADSs or the deposit agreement, we believe that the waiver would likely continue to apply to
purchasers of ADSs in secondary transactions. In addition, we believe that the waiver would likely continue to apply to ADS holders or
beneficial owners who withdraw the ordinary shares from the ADS facility with respect to claims arising before the cancellation of the
ADSs and the withdrawal of the ordinary shares,